British Journal of Clinical Pharmacology

Drug toxicity and surveillance in children
pp. 407-410(4)
Authors: CHOONARA, IMTI; GILL, ANDREA; NUNN, ANTHONY

Mefloquine: the benefits outweigh the risks
pp. 411-413(3)
Author: WINSTANLEY, PETER

Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial
pp. 415-421(7)
Authors: DAVIS, TIMOTHY M. E.; DEMBO, LAWRENCE G.; KAYE-EDDIE, SALLY A.; HEWITT, BENJAMIN J.; HISLOP, ROBERT G.; BATTY, KEVIN T.

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines
pp. 423-429(7)
Authors: SMITH, C. C.; BENNETT, P. M.; PEARCE, H. M.; HARRISON, P. I.; REYNOLDS, D. J. M.; ARONSON, J. K.; GRAHAME-SMITH, D. G.

5-HT_1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519
pp. 431-441(11)
Authors: LONGMORE, J.; BOULANGER, C. M.; DESTA, B.; HILL, R. G.; SCHOFIELD, W. N.; TAYLOR, A. A.

Pharmacokinetics of trapidil, an antagonist of platelet derived growth factor, in healthy subjects and in patients with liver cirrhosis
pp. 443-449(7)
Authors: HARDER, SEBASTIAN; THÜRMANN, PETRA A.; HELLSTERN, ANTON; BENJAMINOV, ANNA

Captopril has no significant scavenging antioxidant activity in human plasma in vitro or in vivo
pp. 451-456(6)
Authors: LAPENNA, DOMENICO; DE GIOIA, SERGIO; CIOFANI, GIULIANO; DANIELE, FRANCA; CUCCURULLO, FRANCO

Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B₄ receptor antagonist
pp. 457-464(8)
Authors: MARDER, P.; SPAETHE, S. M.; FROELICH, L. L.; CERIMELE, B. J.; PETERSEN, B. H.; TANNER, T.; LUCAS, R. A.

Effect of fluconazole dose on the extent of fluconazole-triazolam interaction
pp. 465-470(6)
Authors: VARHE, ANU; OLKKOLA, KLAUS T.; NEUVONEN, PERTTI J.

The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype
pp. 471-474(4)
Authors: WAN, JIE; XIA, HUI; HE, NAN; LU, YI-QING; ZHOU, HONG-HAO

Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary
pp. 475-481(7)
Authors: VAN GERVEN, J. M. A.; SCHOEMAKER, R. C.; JACOBS, L.-D.; REINTS, A.; OUWERSLOOT-VAN DER MEIJ, M. J.; HOEDEMAKER, H. G. J.; COHEN, A. F.

Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study
pp. 483-490(8)
Authors: KEECH, A. C.; ARMITAGE, J. M.; WALLENDSZUS, K. R.; LAWSON, A.; HAUER, A. J.; PARISH, S. E.; COLLINS for the Oxford Cholesterol Study Group, R.

Double-blind comparative study of the antidepressant, unwanted and cardiac effects of minaprine and amitriptyline
pp. 491-498(8)
Authors: EDWARDS, J. GUY; DINAN, TIMOTHY G.; WALLER, DEREK G.; GREENTREE, STEPHEN G.

Assessment of changes in liver blood flow after food intake—comparison of ICG clearance and echo-Doppler
pp. 499-502(4)
Authors: BURGGRAAF, J.; SCHOEMAKER, H. C.; COHEN, A. F.

Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers
pp. 503-506(4)
Authors: SELS, J. P. J. E.; NAUTA, J. J. P.; MENHEERE, P. P. C. A.; WOLFFENBUTTEL, B. H. R.; NIEUWENHUIJZEN KRUSEMAN, A. C.

α-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility
pp. 507-509(3)
Authors: MARSHALL, H. J.; BEEVERS, D. G.

Lack of pharmacokinetic interaction between butorphanol nasal spray and cimetidine
pp. 513-517(5)
Authors: SHYU, W. C.; BARBHAIYA, R. H.

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine
pp. 518-521(4)
Authors: XU, ZHEN-HUA; XIE, HONG-GUANG; ZHOU, HONG-HAO

Effects of frusemide on the urinary excretion of dopamine and 5-hydroxytryptamine in normal man
pp. 522-524(3)
Authors: LI KAM WA, T. C.; FREESTONE, S.; McCRINDLE, J. L.; SAMSON, R. R.; JOHNSTON, N. R.; LEE, M. R.

Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites
pp. 525-527(3)
Authors: LENNARD, L.; WELCH, J.; LILLEYMAN, J. S.